Clinical Trial Update: Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 trial investigating mifepristone dynamic testing for diagnosing central adrenal insufficiency was terminated with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Adrenal Insufficiency

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Tobias Else | Conditions: Central Adrenal Insufficiency, Mifepristone | Phase 2 | Status: TERMINATED | Results posted: 2023-06-12